Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer

Clinical trial NCT02595138 · UNKNOWN

Trial details

NCT number: NCT02595138
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2015-10-01
Primary completion: 2018-10-01
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.